Post-approval change misclassified during agency query response – FDA/EMA expectations and how to respond
Identifying the symptoms of misclassified post-approval changes is critical for timely and effective remediation. Symptoms may manifest as discrepancies in documentation, unexpected deviations during manufacturing, or inconsistencies in product quality.…